TD Asset Management
ITCI

TD Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-72,648
Closed -$5.2M 1446
2023
Q4
$5.2M Buy
+72,648
New +$5.2M 0.01% 756
2020
Q4
Sell
-16,916
Closed -$434K 1484
2020
Q3
$434K Sell
16,916
-6,412
-27% -$165K ﹤0.01% 1271
2020
Q2
$599K Sell
23,328
-12,400
-35% -$318K ﹤0.01% 1181
2020
Q1
$549K Buy
35,728
+5,728
+19% +$88K ﹤0.01% 1157
2019
Q4
$1.03M Buy
+30,000
New +$1.03M ﹤0.01% 1085
2019
Q3
Sell
-14,900
Closed -$193K 1374
2019
Q2
$193K Buy
14,900
+700
+5% +$9.07K ﹤0.01% 1300
2019
Q1
$173K Hold
14,200
﹤0.01% 1313
2018
Q4
$162K Sell
14,200
-6,900
-33% -$78.7K ﹤0.01% 1362
2018
Q3
$458K Sell
21,100
-16,600
-44% -$360K ﹤0.01% 1308
2018
Q2
$666K Sell
37,700
-11,400
-23% -$201K ﹤0.01% 1210
2018
Q1
$1.03M Buy
+49,100
New +$1.03M ﹤0.01% 1051
2017
Q2
Sell
-14,000
Closed -$228K 1377
2017
Q1
$228K Sell
14,000
-1,300
-8% -$21.2K ﹤0.01% 1356
2016
Q4
$231K Buy
15,300
+1,100
+8% +$16.6K ﹤0.01% 1325
2016
Q3
$216K Buy
+14,200
New +$216K ﹤0.01% 1355